Lumanity is about transformation; we apply incisive thinking and decisive action to cut through complex situations and deliver transformative outcomes to accelerate and optimize access to medical advances
Meet our team of passionate, collaborative people who inspire incisive thinking and decisive action
Innovation doesn’t guarantee success. But when diverse minds come together to focus on key issues, incredible change can unfold. Lumanity embraces unique viewpoints and experiences to develop better solutions and improved outcomes for patients.
We are Changemakers.
Whether you’re an experienced professional or a recent graduate, join Lumanity to make a difference. We are a collaborative, global team—no matter where you live, you can help us build a healthier world.
Differentiated platforms for soluble TCRs, bifunctional TCRs, and TCR cell therapies.
Positioning could range across a variety of cancer types and settings, targeting various known and/or novel cell surface targets
Elucidate potential optimal paths forward: which targets and their best allied technologies (soluble or cell-based) for which indications to be pursued for an innovative but early-stage platform
Identification of key differentiating features of the platform within the context of extant unmet needs and the rapidly evolving competitive landscape
Vetting nature of targets and their supporting data to align with tumor setting, and value proposition for soluble biologic versus cell therapy
Undertook extensive analytics to identify potential targets, modality and indications–and developed customized scoring criteria
Provided support and insight to underpin relevant scientific, clinical, and commercial considerations
Provided a well-supported tool to identify most attractive targets and indications to be pursued
Enabled ability to generate rank-ordered lists & diversified suite of candidates associated with alternative corporate priorities such as spee to market, attractiveness to potential partners, or competitive gaps
Subsequent deals have been done around the programs we helped prioritize